세계의 헬스케어용 인공지능 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)

The global demand for Artificial Intelligence In Healthcare Market is presumed to reach the market size of nearly USD 398 Billion by 2032 from USD 19.45 Billion in 2023 with a CAGR of 39.85% under the study period 2024-2032.

Artificial Intelligence (AI) in healthcare refers to the use of algorithms and machine learning models to improve medical services, from diagnostics to personalized treatment. AI applications include analyzing medical images, predicting disease risk, automating administrative tasks, and enhancing patient care through virtual assistants. By processing large datasets, AI systems can identify patterns and trends that may be missed by humans, accelerating diagnoses and improving treatment accuracy. With potential to increase operational efficiency, reduce errors, and enhance patient outcomes, AI in healthcare is transforming the industry, making it more proactive and data-driven while reducing costs and expanding accessibility.

Market Dynamics

The artificial intelligence in healthcare market is experiencing rapid growth due to advancements in AI-driven diagnostics, personalized medicine, and administrative efficiency. AI applications in imaging diagnostics are enhancing the accuracy and speed of detecting diseases like cancer, significantly improving patient outcomes. The development of personalized medicine solutions, powered by AI algorithms, is enabling more targeted treatments and drug formulations based on individual patient profiles, increasing the demand for artificial intelligence in healthcare. Furthermore, AI-powered tools are being used to streamline administrative tasks, such as patient scheduling, billing, and data management, thereby reducing operational costs for healthcare providers. The rise of telemedicine and remote patient monitoring, which use AI to assess patient data and manage chronic conditions, has further fueled the artificial intelligence in healthcare market, especially during and after the COVID-19 pandemic. Additionally, AI's role in drug discovery is accelerating, as it shortens research timelines and enhances efficiency in pharmaceutical research. However, data privacy concerns and high implementation costs may challenge the Artificial Intelligence in Healthcare market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Artificial Intelligence In Healthcare. The growth and trends of Artificial Intelligence In Healthcare industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Artificial Intelligence In Healthcare market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Offering

• Software (Machine Learning, Natural Language Processing, Context-aware Computing, Computer vision)
• Services

By Application

• Medical Imaging & Diagnosis
• Drug Discovery
• Therapy Planning
• Hospital Workflow
• Wearables
• Virtual Assistants
• Other Applications

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Artificial Intelligence In Healthcare market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Artificial Intelligence In Healthcare market include Aidoc, AiCure, Apixio Inc., Atomwise Inc., Butterfly Network, Dassault Systemes (Medidata), Enlitic Inc., Koninklijke Philips N.V., IBM Corporation, ICarbonX, Insilico Medicine Inc, Itrex Group, IQVIA, Nvidia Corporation, Sophia Genetics. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. ARTIFICIAL INTELLIGENCE IN HEALTHCARE - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Offering
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET ANALYSIS BY OFFERING

• 5.1. Overview By Offering
• 5.2. Historical and Forecast Data
• 5.3. Analysis By Offering
• 5.4. Software (Machine Learning, Natural Language Processing, Context-aware Computing, Computer vision) Historic and Forecast Sales By Regions
• 5.5. Services Historic and Forecast Sales By Regions

6. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET ANALYSIS BY APPLICATION

• 6.1. Overview By Application
• 6.2. Historical and Forecast Data
• 6.3. Analysis By Application
• 6.4. Medical Imaging & Diagnosis Historic and Forecast Sales By Regions
• 6.5. Drug Discovery Historic and Forecast Sales By Regions
• 6.6. Therapy Planning Historic and Forecast Sales By Regions
• 6.7. Hospital Workflow Historic and Forecast Sales By Regions
• 6.8. Wearables Historic and Forecast Sales By Regions
• 6.9. Virtual Assistants Historic and Forecast Sales By Regions
• 6.10. Other Applications Historic and Forecast Sales By Regions

7. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET ANALYSIS BY GEOGRAPHY

• 7.1. Regional Outlook
• 7.2. Introduction
• 7.3. North America Sales Analysis
  • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.3.2 North America By Segment Sales Analysis
  • 7.3.3 North America By Country Sales Analysis
  • 7.3.4 United States Sales Analysis
  • 7.3.5 Canada Sales Analysis
  • 7.3.6 Mexico Sales Analysis
• 7.4. Europe Sales Analysis
  • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.4.2 Europe By Segment Sales Analysis
  • 7.4.3 Europe By Country Sales Analysis
  • 7.4.4 United Kingdom Sales Analysis
  • 7.4.5 France Sales Analysis
  • 7.4.6 Germany Sales Analysis
  • 7.4.7 Italy Sales Analysis
  • 7.4.8 Russia Sales Analysis
  • 7.4.9 Rest Of Europe Sales Analysis
• 7.5. Asia Pacific Sales Analysis
  • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.5.2 Asia Pacific By Segment Sales Analysis
  • 7.5.3 Asia Pacific By Country Sales Analysis
  • 7.5.4 China Sales Analysis
  • 7.5.5 India Sales Analysis
  • 7.5.6 Japan Sales Analysis
  • 7.5.7 South Korea Sales Analysis
  • 7.5.8 Australia Sales Analysis
  • 7.5.9 South East Asia Sales Analysis
  • 7.5.10 Rest Of Asia Pacific Sales Analysis
• 7.6. Latin America Sales Analysis
  • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.6.2 Latin America By Segment Sales Analysis
  • 7.6.3 Latin America By Country Sales Analysis
  • 7.6.4 Brazil Sales Analysis
  • 7.6.5 Argentina Sales Analysis
  • 7.6.6 Peru Sales Analysis
  • 7.6.7 Chile Sales Analysis
  • 7.6.8 Rest of Latin America Sales Analysis
• 7.7. Middle East & Africa Sales Analysis
  • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.7.2 Middle East & Africa By Segment Sales Analysis
  • 7.7.3 Middle East & Africa By Country Sales Analysis
  • 7.7.4 Saudi Arabia Sales Analysis
  • 7.7.5 UAE Sales Analysis
  • 7.7.6 Israel Sales Analysis
  • 7.7.7 South Africa Sales Analysis
  • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE ARTIFICIAL INTELLIGENCE IN HEALTHCARE COMPANIES

• 8.1. Artificial Intelligence In Healthcare Market Competition
• 8.2. Partnership/Collaboration/Agreement
• 8.3. Merger And Acquisitions
• 8.4. New Product Launch
• 8.5. Other Developments

9. COMPANY PROFILES OF ARTIFICIAL INTELLIGENCE IN HEALTHCARE INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Market Concentration Rate
• 9.3. Aidoc
  • 9.3.1 Company Overview
  • 9.3.2 Company Revenue
  • 9.3.3 Products
  • 9.3.4 Recent Developments
• 9.4. AiCure
  • 9.4.1 Company Overview
  • 9.4.2 Company Revenue
  • 9.4.3 Products
  • 9.4.4 Recent Developments
• 9.5. Apixio Inc.
  • 9.5.1 Company Overview
  • 9.5.2 Company Revenue
  • 9.5.3 Products
  • 9.5.4 Recent Developments
• 9.6. Atomwise Inc.
  • 9.6.1 Company Overview
  • 9.6.2 Company Revenue
  • 9.6.3 Products
  • 9.6.4 Recent Developments
• 9.7. Butterfly Network
  • 9.7.1 Company Overview
  • 9.7.2 Company Revenue
  • 9.7.3 Products
  • 9.7.4 Recent Developments
• 9.8. Dassault Systemes (Medidata)
  • 9.8.1 Company Overview
  • 9.8.2 Company Revenue
  • 9.8.3 Products
  • 9.8.4 Recent Developments
• 9.9. Enlitic Inc.
  • 9.9.1 Company Overview
  • 9.9.2 Company Revenue
  • 9.9.3 Products
  • 9.9.4 Recent Developments
• 9.10. Koninklijke Philips N.V.
  • 9.10.1 Company Overview
  • 9.10.2 Company Revenue
  • 9.10.3 Products
  • 9.10.4 Recent Developments
• 9.11. IBM Corporation
  • 9.11.1 Company Overview
  • 9.11.2 Company Revenue
  • 9.11.3 Products
  • 9.11.4 Recent Developments
• 9.12. ICarbonX
  • 9.12.1 Company Overview
  • 9.12.2 Company Revenue
  • 9.12.3 Products
  • 9.12.4 Recent Developments
• 9.13. Insilico Medicine Inc
  • 9.13.1 Company Overview
  • 9.13.2 Company Revenue
  • 9.13.3 Products
  • 9.13.4 Recent Developments
• 9.14. Itrex Group
  • 9.14.1 Company Overview
  • 9.14.2 Company Revenue
  • 9.14.3 Products
  • 9.14.4 Recent Developments
• 9.15. IQVIA
  • 9.15.1 Company Overview
  • 9.15.2 Company Revenue
  • 9.15.3 Products
  • 9.15.4 Recent Developments
• 9.16. Nvidia Corporation
  • 9.16.1 Company Overview
  • 9.16.2 Company Revenue
  • 9.16.3 Products
  • 9.16.4 Recent Developments
• 9.17. Sophia Genetics
  • 9.17.1 Company Overview
  • 9.17.2 Company Revenue
  • 9.17.3 Products
  • 9.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies